The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.

CONCLUSIONS: The imaging and histological characteristics of BRCA1/2 mutation carriers were consistent with other countries' studies. MRI-detected lesions were significantly smaller than lesions detected by non-MRI modality. All lesions in BRCA1 mutation carriers could be detected by MRI.
PMID: 30820924 [PubMed - as supplied by publisher]

Source: Breast Cancer - February 27, 2019 Category: Cancer & Oncology Authors: Murakami W, Tozaki M, Nakamura S, Ide Y, Inuzuka M, Hirota Y, Murakami K, Takahama N, Ohgiya Y, Gokan T Tags: Breast Cancer Source Type: research